On this page
Read the experiment
The finding and its boundary
The authors reported reduced bleeding-related measures and attenuation of platelet-count changes in the tested conditions. The work does not establish a clinical anticoagulant reversal treatment or safe routine co-use.
Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.
- Experiment
- Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
- Study system
- Rats after tail amputation with heparin or warfarin and NO modifiers
- Measured outcome
- Bleeding, platelet counts and hemostatic measures
- Reported result
- The authors reported reduced bleeding-related measures and attenuation of platelet-count changes in the tested conditions.
- What this cannot establish
- The work does not establish a clinical anticoagulant reversal treatment or safe routine co-use.
What was actually tested
Rats after tail amputation with heparin or warfarin and NO modifiers. The investigators measured bleeding, platelet counts and hemostatic measures. The authors reported reduced bleeding-related measures and attenuation of platelet-count changes in the tested conditions.
The detail that changes the takeaway
A reduction in bleeding can be useful in one model while raising questions about intended antithrombotic treatment in another. Both sides of the clinical tradeoff matter. The experiment cannot tell a patient whether altering a prescribed anticoagulant is appropriate or safe.
How far the result travels
The work does not establish a clinical anticoagulant reversal treatment or safe routine co-use.
A useful comparison
BPC-157 and bleeding after amputation in rats examines bleeding amount/time, platelet counts and selected coagulation measures. Here, the measured endpoint was bleeding, platelet counts and hemostatic measures. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the Can one BPC-157 study support the product in front of you? appraisal.
References & product documents
The evidence and service information used here.